O
Oruka Therapeutics, Inc.
ORKA · NASDAQ · Healthcare · 3.3B
Price · close
$111.04
+2.70% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
10.7×
Enterprise value / EBITDAEV/EBITDA
-47.7×
Free cash flow yieldFCF yield
-1.7%
Return on equityROE
-22.3%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.4×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.